Biological evaluation of medical devices. Part 1: Evaluation and testing within a risk management process (ISO 10993-1:2018, including corrected version 2018-10)
Tuote ladattavissa hetiToimitusaika on noin 1 - 2 työpäivääToimitusaika on 3 - 5 työpäivää.
This document specifies: — the general principles governing the biological evaluation of medical devices within a risk management process; — the general categorization of medical devices based on the nature and duration of their contact with the body; — the evaluation of existing relevant data from all sources; — the identification of gaps in the available data set on the basis of a risk analysis; — the identification of additional data sets necessary to analyse the biological safety of the medical device; — the assessment of the biological safety of the medical device. This document applies to evaluation of materials and medical devices that are expected to have direct or indirect contact with: — the patient's body during intended use; — the user's body, if the medical device is intended for protection (e.g., surgical gloves, masks and others). This document is applicable to biological evaluation of all types of medical devices including active, non-active, implantable and non-implantable medical devices. This document also gives guidelines for the assessment of biological hazards arising from: — risks, such as changes to the medical device over time, as a part of the overall biological safety assessment; — breakage of a medical device or medical device component which exposes body tissue to new or novel materials. Other parts of ISO 10993 cover specific aspects of biological assessments and related tests. Device-specific or product standards address mechanical testing. This document excludes hazards related to bacteria, moulds, yeasts, viruses, transmissible spongiform encephalopathy (TSE) agents and other pathogens.
Tämän julkaisun valmistelusta Suomessa vastaa Palvelualojen työnantajat PALTA ry, puh. 040 579 4393.
Sisällysluettelo
Foreword
Introduction
1 Scope
2 Normative references
3 Terms and definitions
4 General principles applying to biological evaluation of medical devices
5 Categorization of medical devices
5.1 General
5.2 Categorization by nature of body contact
5.3 Categorization by duration of contact
6 Biological evaluation process
6.1 Physical and chemical information for biological risk analysis
6.2 Gap analysis and selection of biological endpoints for assessment
6.3 Biological testing
7 Interpretation of biological evaluation data and overall biological risk assessment
Annex A Endpoints to be addressed in a biological risk assessment (informative)
Annex B Guidance on the conduct of biological evaluation within a risk management process (informative)
Annex C Suggested procedure for literature review (informative)
ISO 10993-10:2010 Biological evaluation of medical devices -- Part 10: Tests for irritation and skin sensitization
ISO 10993-11:2017 Biological evaluation of medical devices -- Part 11: Tests for systemic toxicity
ISO 10993-12:2012 Biological evaluation of medical devices -- Part 12: Sample preparation and reference materials
ISO 10993-10:2010 Biological evaluation of medical devices -- Part 10: Tests for irritation and skin sensitization
ISO 10993-11:2017 Biological evaluation of medical devices -- Part 11: Tests for systemic toxicity
ISO 10993-12:2012 Biological evaluation of medical devices -- Part 12: Sample preparation and reference materials
ISO 10993-13:2010 Biological evaluation of medical devices -- Part 13: Identification and quantification of degradation products from polymeric medical devices
ISO 10993-14:2001 Biological evaluation of medical devices -- Part 14: Identification and quantification of degradation products from ceramics
ISO 10993-15:2019 Biological evaluation of medical devices -- Part 15: Identification and quantification of degradation products from metals and alloys
ISO 10993-16:2017 Biological evaluation of medical devices -- Part 16: Toxicokinetic study design for degradation products and leachables
ISO 10993-17:2002 Biological evaluation of medical devices -- Part 17: Establishment of allowable limits for leachable substances
ISO 10993-18:2020 Biological evaluation of medical devices -- Part 18: Chemical characterization of medical device materials within a risk management process
ISO 10993-2:2006 Biological evaluation of medical devices -- Part 2: Animal welfare requirements
ISO 10993-3:2014 Biological evaluation of medical devices -- Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity
ISO 10993-4:2017 Biological evaluation of medical devices -- Part 4: Selection of tests for interactions with blood
ISO 10993-5:2009 Biological evaluation of medical devices -- Part 5: Tests for in vitro cytotoxicity
ISO 10993-6:2016 Biological evaluation of medical devices -- Part 6: Tests for local effects after implantation
ISO 10993-7:2008 Biological evaluation of medical devices -- Part 7: Ethylene oxide sterilization residuals
ISO 10993-9:2019 Biological evaluation of medical devices -- Part 9: Framework for identification and quantification of potential degradation products
ISO 14971:2007 Medical devices -- Application of risk management to medical devices
ISO/TS 10993-20:2006 Biological evaluation of medical devices -- Part 20: Principles and methods for immunotoxicology testing of medical devices
[could not compute reference] Biological evaluation of medical devices — Part 4: Selection of tests for interactions with blood